Article

Essilor's Varilux Physio sales pass one million mark

Dallas-Sales of Varilux Physio have surpassed the one million mark, with one million pairs sold worldwide, according to Essilor of America Inc.

Dallas-Sales of Varilux Physio have surpassed the one million mark, with one million pairs sold worldwide, according to Essilor of America Inc.

"This one million sales milestone is very exciting for Varilux Physio," said Carl Bracy, vice president of marketing, Essilor of America Inc. "We are delighted by the market's excitement and the need for WAVE [Wavefront Advanced Vision Enhancement] technology."

In January 2006, Essilor launched Varilux Physio 360° and Varilux Physio lenses to deliver the corrective WAVE technology to presbyopic patients. Studies conducted by Essilor among more than 2,000 patients showed that wearers preferred Varilux Physio no matter what the ametropia, age of the patient, or previous type of lens.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
© 2025 MJH Life Sciences

All rights reserved.